Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Witold Ruzyllo

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
European Heart Journal|February 25, 2014
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trialSigrun Halvorsen, Dan Atar, Hongqiu Yang, et al.
Circulation. Cardiovascular Interventions|February 22, 2018
Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet TherapyRadoslaw Pracon, Sripal Bangalore, Zofia Dzielinska, et al.
American Heart Journal|May 26, 2009
Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trialSanjiv J Shah, John E A Blair, Gerasimos S Filippatos, et al.
Critical Care Medicine|August 29, 2013
Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shockSean van Diepen, Harmony R Reynolds, Amanda Stebbins, et al.
Circulation|April 5, 2014
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trialMarie-Claude Morice, Patrick W Serruys, A Pieter Kappetein, et al.
European Heart Journal|June 19, 2010
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 TrialBenjamin M Scirica, David A Morrow, Christoph Bode, et al.
American Heart Journal|August 25, 2009
Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 yearsChristopher E Buller, Jamie M Rankin, Ronald G Carere, et al.
Circulation|October 26, 2011
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarctionJudith S Hochman, Harmony R Reynolds, Vladimír Dzavík, et al.
American Heart Journal|March 20, 2012
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT)Harmony R Reynolds, Sandra A Forman, Jacqueline E Tamis-Holland, et al.
Circulation|December 24, 2003
Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trialKengo Tanabe, Patrick W Serruys, Muzaffer Degertekin, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
European Heart Journal|February 25, 2014
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trialSigrun Halvorsen, Dan Atar, Hongqiu Yang, et al.
Circulation. Cardiovascular Interventions|February 22, 2018
Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet TherapyRadoslaw Pracon, Sripal Bangalore, Zofia Dzielinska, et al.
American Heart Journal|May 26, 2009
Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trialSanjiv J Shah, John E A Blair, Gerasimos S Filippatos, et al.
Critical Care Medicine|August 29, 2013
Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shockSean van Diepen, Harmony R Reynolds, Amanda Stebbins, et al.
Circulation|April 5, 2014
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trialMarie-Claude Morice, Patrick W Serruys, A Pieter Kappetein, et al.
European Heart Journal|June 19, 2010
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 TrialBenjamin M Scirica, David A Morrow, Christoph Bode, et al.
American Heart Journal|August 25, 2009
Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 yearsChristopher E Buller, Jamie M Rankin, Ronald G Carere, et al.
Circulation|October 26, 2011
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarctionJudith S Hochman, Harmony R Reynolds, Vladimír Dzavík, et al.
American Heart Journal|March 20, 2012
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT)Harmony R Reynolds, Sandra A Forman, Jacqueline E Tamis-Holland, et al.
Circulation|December 24, 2003
Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trialKengo Tanabe, Patrick W Serruys, Muzaffer Degertekin, et al.
Pageof 11